What is LPCN's gross margin?

Lipocine (LPCN) has a gross margin of 100% and a net margin of -1380%.

What is LPCN's P/E ratio?

Track Lipocine (LPCN) P/E ratio, ROE, and valuation metrics over time.

Where can I see LPCN's full financials?

See Lipocine (LPCN) income statement, cash flow, and balance sheet — quarterly and annual — alongside insider trading activity.

Lipocine (LPCN) Financials — Revenue, Earnings, Cash Flow

$2.05

-0.02 (-0.97%)

Weekly Expected Move ±5.4%

$2 $2 $2 $2 $2

NASDAQ · Healthcare · Biotechnology · Tech Score Sell · Power 31 · $16.9M mcap · 8M float · 0.730% daily turnover · Short 36% of daily vol

📊 Key Metrics

TTM

$2M

Revenue

-62.7% YoY

$-12M

Net Income

-162.9% YoY

$-11M

Free Cash Flow

-120.4% YoY

100.0%

Gross Margin

-1495.1%

Op. Margin

-1379.6%

Net Margin

💰 Income Flow

How revenue becomes profit

💵 Cash Flow

⚠️ Cash Burn Where cash goes

🏦 Balance Sheet

Assets = Liabilities + Equity

📈 Financial Health

Profitability

ROE-60.9%

ROA-55.9%

ROIC662.3%

Valuation

P/E-1.1

P/B0.8

EV/EBITDA0.2

Leverage

Debt/Equity0.00

Current Ratio11.48

Interest Cov.0.0x

Quality Scores

Piotroski F2/9

Altman Z-7.07

Beneish M0.78